SCHEMBL16270268

SCHEMBL16270268

CCOC(=O)[C@H](O)C[C@@H](Cc1ccc(-c2cccc(Cl)c2)cc1)NC(=O)C(=O)CC

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 18/20 0.69
▸ ACE P12821 9/20 0.69
▸ MMEL1 Q495T6 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18598040 0.91 MME (0.70) MMEACEMMEL1
SCHEMBL14891211 0.91 MME (0.82) MMEACEMMEL1
SCHEMBL14890588 0.91 MME (0.70) MMEACEMMEL1
SCHEMBL16011776 0.91 MME (0.82) MMEACEMMEL1
SCHEMBL18597739 0.91 MME (0.82) MMEACEMMEL1
SCHEMBL18783219 0.90 MME (0.69) MMEACEMMEL1
SCHEMBL16008239 0.90 MME (0.80) MMEACEMMEL1
SCHEMBL19708727 0.88 MME (0.64) MMEACEMMEL1
SCHEMBL14890709 0.85 MME (0.79) MMEACEMMEL1
SCHEMBL18597986 0.85 MME (0.79) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8901169-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2014-12-02 — — US disclosed
US-8901169-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2014-12-02 — — US disclosed
Send feedback